NEW YORK, July 31, 2014 /PRNewswire/ --
Today, Analysts Review released its research reports regarding Express Scripts Holding Company (NASDAQ: ESRX), General Electric Company (NYSE: GE), D.R. Horton Inc. (NYSE: DHI), Rite Aid Corporation (NYSE: RAD) and Sirius XM Holdings Inc. (NASDAQ: SIRI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5296-100free.
--
Express Scripts Holding Company Research Reports
On July 17, 2014, Express Scripts Holding Company (Express Scripts) released a new state-by-state analysis according to which, State Governments may spend more than $55 billion on hepatitis C medications. The Company informed the high drug costs will lead to major financial adjustments for State Budgets. Steve Miller, M.D., Chief Medical Officer, Express Scripts, said, "There is no doubt that Sovaldi is a breakthrough therapy, but unfortunately, it is also likely to break state budgets. Since healthcare for so many hepatitis C patients is funded by state programs, each citizen will be shouldering the unprecedented cost burden. The unsustainable pricing of this medication has essentially become a tax on all Americans." The full research reports on Express Scripts are available to download free of charge at:
http://www.analystsreview.com/Jul-31-2014/ESRX/report.pdf
--
GeneralElectric Company Research Reports
On July 28, 2014, General Electric Company (GE) announced that its GE Capital's Franchise Finance business has loaned $39.4 million to Cotti Foods for the acquisition of 39 Wendy's restaurants, renovation of current units and development of new units. The Company informed that Cotti purchased the units from Wendy's International Inc. Todd Cortell, Senior Vice President, GE Capital, Franchise Finance, said, "We're pleased to help Pete and his team undertake this expansion. We have a long-standing relationship with Wendy's and its franchisees, and we're committed to providing capital that enables both groups to grow, so it's exciting to participate with Pete and Cotti Foods as they join the brand." The full research reports on GE are available to download free of charge at:
http://www.analystsreview.com/Jul-31-2014/GE/report.pdf
--
D.R. Horton Inc. Research Reports
On July 24, 2014, D.R. Horton, Inc. (D.R. Horton) reported financial results for Q3 FY 2014 (period ended June 30, 2014). Net sales for the quarter reached 8,551 homes amounting to $2.4 billion, as compared to 6,822 homes amounting to $1.8 billion in Q3 FY 2014. Homebuilding revenue stood at $2.1 billion, up 27.9% YoY and homes closed during the period increased to 7,676, up 18.8% YoY. Net income was at $113.1 million, or $0.32 per diluted share, as compared to $146.0 million, or $0.42 per diluted share in Q3 FY 2013. The Company added that it has declared a quarterly cash dividend of $0.06 per common share, payable on August 18, 2014 to stockholders of record on August 8, 2014. The full research reports on D.R. Horton are available to download free of charge at:
http://www.analystsreview.com/Jul-31-2014/DHI/report.pdf
--
Rite Aid Corporation Research Reports
On July 24, 2014, Rite Aid Corporation (Rite Aid) announced that Darren Karst will join Rite Aid as Executive Vice President and CFO, effective from August 20, 2014. The Company informed that Mr. Karst will succeed Frank Vitrano, who will be retiring on September, 2015. According to Rite Aid, until then, Mr. Vitrano retains the Chief Administrative Officer responsibilities for the Company's information technology, real estate and indirect procurement functions. The Company stated that, Mr. Karst in his new role will be responsible for all aspects of its finance, accounting, treasury, tax, investor relations, legal, risk management, internal assurance and asset protection functions and he will report to Rite Aid's Chairman and CEO, John Standley. "We are pleased to welcome Darren to the Rite Aid team," said Standley. "He is a proven leader with a broad-based financial background and a track record of success across a range of operating and financial disciplines." The full research reports on Rite Aid are available to download free of charge at:
http://www.analystsreview.com/Jul-31-2014/RAD/report.pdf
--
Sirius XM Holdings Inc. Research Reports
On July 24, 2014, Sirius XM Holdings Inc. (SiriusXM) announced that Tom Petty Radio will air on SiriusXM's Classic Rewind channel through Sunday, August 3, 2014. The channel will feature music covering Petty's entire career, which includes his first album with The Heartbreakers as well as the new album Hypnotic Eye. Scott Greenstein, President and Chief Content Officer, SiriusXM, said, "Tom Petty has written and performed some of the most legendary and loved music of the recent decades, and he is followed by a legion of fans that cross generations, We're excited to bring all his music together in one place for a truly special and unique channel." The full research reports on SiriusXM are available to download free of charge at:
http://www.analystsreview.com/Jul-31-2014/SIRI/report.pdf
--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
AnalystsReview.com
SOURCE Analysts Review
